Foresite Capital Management IV’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,332,616
| Closed | -$10.4M | – | 14 |
|
|
2020
Q3 | $10.4M | Buy |
+3,332,616
| New | +$10.4M | 2.35% | 11 |
|
|
2020
Q1 | – | Sell |
-3,705,128
| Closed | -$10.3M | – | 12 |
|
|
2019
Q4 | $10.3M | Buy |
+3,705,128
| New | +$10.3M | 4.44% | 8 |
|
|
2019
Q3 | – | Sell |
-608,151
| Closed | -$1.27M | – | 18 |
|
|
2019
Q2 | $1.27M | Sell |
608,151
-196,295
| -24% | -$408K | 0.36% | 19 |
|
|
2019
Q1 | $2.88M | Sell |
804,446
-777,829
| -49% | -$2.78M | 1.04% | 15 |
|
|
2018
Q4 | $6.06M | Sell |
1,582,275
-1,094,550
| -41% | -$4.19M | 2.78% | 12 |
|
|
2018
Q3 | $25.3M | Buy |
2,676,825
+25,000
| +0.9% | +$236K | 8.29% | 5 |
|
|
2018
Q2 | $19.4M | Buy |
2,651,825
+1,166,580
| +79% | +$8.52M | 6.6% | 8 |
|
|
2018
Q1 | $7.43M | Buy |
1,485,245
+1,334,653
| +886% | +$6.67M | 3.08% | 12 |
|
|
2017
Q4 | $760K | Buy |
+150,592
| New | +$760K | 0.53% | 13 |
|